LOS ANGELES, January 21, 2022 /PRNewswire/ — In the latest episode of trend today, broadcast on Fox Business, Apprentice.io shares its revolutionary technology for personalized medicine. look saturday 29 january at 12:30 p.m. EST to learn why Apprentice.io developed a cloud-based platform called Tempo to accelerate the production of new drugs and therapies.

“The Tempo Manufacturing Cloud is a modern and intuitive solution for life sciences that works seamlessly through all stages of drug production to transform a discovered molecule into a delivered drug. The platform is essential for manufacturers are transferring their operations to produce next-generation therapies like biologics and personalized medicine – a specific batch of medicines made just for you,” says Angelo Stracquatanio III, CEO of Apprenti.io. He co-founded the company, based in Jersey City, New Jersey, with Gary Pignata and Alexandra Buttke in 2014.

According to Apprentice.io, 15 of the top 20 US pharmaceutical companies are using its technology to accelerate the production of high-quality drugs. “Our intelligent software platform helps pharmaceutical companies eliminate paper-based processes and more efficiently manage the production of therapies for all types of diseases, from COVID to cancer. It also helps ensure drugmakers plan their resources better, meet the highest quality standards, and use real-time data from the system to continuously monitor and improve,” says Stracquatanio.

Throughout the pandemic, Apprentice.io has helped produce approximately 370 million doses of the COVID-19 vaccine. “We’re helping modernize the life sciences to get us out of this pandemic and help the next wave of therapies come to market,” Stracquatanio said.

The episode also features apprentice customers Synthego, a genome engineering company that accelerates life science research and development to improve human health, and Catalent, the global leader that enables pharmaceutical partners , biotech and consumer healthcare to optimize product development, launch and commercialization. life-cycle supply for patients worldwide, and the apprentice investor, Silverton Partners, a venture capital fund focused on financing and mentoring start-up companies.

About today’s trends:
Trending Today is a trade show that features entrepreneurs and companies that are disrupting and innovating the business world. Find out how they’re building their brands as Trending guests share their stories and expertise to inspire entrepreneurship. Today airs Fox Business Saturdays at 12:30 p.m. EST. Learn more about the show at www.TrendingToday.com

About the apprentice
Apprentice’s disruptive technology helps pharmaceutical manufacturers get drugs to patients faster by providing a single platform to turn molecules into drugs. The Company’s Tempo Manufacturing Cloud integrates augmented reality, voice recognition and artificial intelligence into wearable, mobile and desktop devices to deliver a virtual collaboration application and a robust lab manufacturing and execution system that reduces human error and inefficiency in the drug production process. Learn how 15 of the top 20 US pharmaceutical companies are using Apprentice to accelerate the production of high-quality drugs for all types of diseases, from COVID to cancer, at www.apprentice.io

Media contacts:
Liz Plumer, Executive Producer, C: 561 201 0506, [email protected]
Karen LeBlanc, director of publicity, C: 407.416.1566, [email protected]

SOURCE trending today